Phase 3 Placeholder

by | Sep 12, 2020

This is a placeholder. It's hidden from the grid/chart , but necessary to display the filter option until real projects have this category. Keep the category "Hidden"...

Phase 2 Placeholder

by | Sep 12, 2020

This is a placeholder. It's hidden from the grid/chart , but necessary to display the filter option until real projects have this category. Keep the category "Hidden"...

Phase 1 Placeholder

by | Sep 12, 2020

This is a placeholder. It's hidden from the grid/chart , but necessary to display the filter option until real projects have this category. Keep the category "Hidden"...

Undisclosed Targets

by | Sep 12, 2020

We are actively engaged in discovery-stage programs investigating multiple undisclosed programs targeting key molecular drivers in...

CDK12 / KIN004

by | Sep 12, 2020

We are also advancing a number of other small molecule development programs, including a CDK12 inhibitor. CDK12 is an essential regulator of DNA damage response genes against which no targeted therapies are currently approved or, to our knowledge, in clinical...